restricted epitope is confirmed using splenocytes stimulated in vitro with either MHV-JHM-infected MC57 cells or with a cell line expressing the S protein and analyzed in secondary CTL assays. To determine whether these results represent a difference in epitope recognition between the spleen and CNS, secondary CTL assays were performed using spleen cells coated with peptides encompassing the CTL epitopes as stimulators. Under these conditions, both epitopes sensitized cells for lysis by spleen-derived CTLs, suggesting that both epitopes were recognized by splenic CD8
/ T cells after infection in vivo. Furthermore, limiting dilution analysis indicated that the precursor frequency of splenic CD8 / T cells specific for both the H-2K b -and H-2D b -restricted epitopes were not significantly different. Thus, the results suggest that in vitro stimulation of splenocytes specific for the H-2K b -restricted epitope is inefficient after endogenous processing but that this inefficiency can be corrected if peptide is provided exogenously at sufficiently high concentrations. As a consequence, the results also show that cells responsive to both of the previously identified CNS-derived CD8 / T cell epitopes are present in the infected spleen at nearly the same frequency. ᭧ 1996 Academic Press, Inc.
MHV-JHM causes acute encephalitis and acute and
(26) or S-specific immunogenic peptides S510-518 or S598-605 (unpublished observations) in direct ex vivo chronic demyelinating encephalomyelitis in susceptible CTL assays using cells isolated from the spleens of mice mice and rats (3-8). The chronic disease results either with acute encephalitis. Bergmann et al., however, were if mice are infected with an attenuated variant of MHV able to isolate S protein-specific CD8 / T cell clones from or if they are protected from the acute encephalitis by a the spleens of B6 mice infected intraperitoneally with a passive infusion of anti-viral antibodies, CD4
/ T cells or sublethal dose of virus. These clones only recognized CD8 / T cells (6, (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . This chronic neurological disease one of the two epitopes which we identified in the direct has been studied as an animal model of human demyex vivo CTL assays. The same results were obtained elinating disease, including multiple sclerosis.
when spleen cells were analyzed in CTL assays after Both CD4
/ and CD8 / T cells are required for virus secondary stimulation in vitro with MHV-infected spleen clearance (23-25). Target proteins for CD8 / T cell cytocells (2). toxicity have been identified in MHV-JHM-infected BALB/ In many cases, antigen-specific cytotoxicity by cells c and C57Bl/6 (B6) mice. In BALB/c mice, the majority of primed in vivo can only be demonstrated after secondary the CTL activity is directed against the nucleocapsid (N) in vitro stimulation with antigen. Conversely, there are protein, whereas in B6 mice, the S glycoprotein is the no reports identifying epitopes which are observed in predominant target (26, 27) . Using cells isolated from the primary but not secondary cytotoxic T cell assays. The CNS of B6 mice with acute encephalitis and analyzed results described above, therefore, would be most condirectly ex vivo in cytotoxicity assays, we identified two sistent with different epitope recognition between efimmunogenic CD8
/ T cell epitopes within the S protein fectors harvested from peripheral lymphoid tissue and (1). In contrast to these results, we could not identify a those harvested from the site of inflammation, the brain. significant amount of CTL activity against the S protein Alternatively, insufficient presentation of the H-2K b -restricted epitope in vitro and consequent inefficient expansion of lymphocytes primed in vivo to respond to this In a second approach, we constructed EL-4 cell clones CD8 / T cell line specific for the S protein, B6 mice were infected intraperitoneally (i.p.) with a sublethal dose of MHV-JHM (2.5 1 10 5 which constitutively expressed the S glycoprotein as de-PFU). Eight days later, splenocytes were harvested as described prescribed previously (1). Individual G418-resistant clones control (EL-4). The average spontaneous release for EL-4 targets corresponded to õ13% and for MC57 cells õ25%. Percentage of specific For this purpose, splenocytes were harvested 8 days release was calculated as described previously (26).
after intraperitoneal inoculation and restimulated in vitro with EL-4-S35 cells. When analyzed in CTL assays, these cells recognized the H-2D b , but not the H-2K b -restricted stricted epitopes. Irradiated splenocytes were coated with both peptides at a concentration of 5 mM each, epitope (Fig. 1B) . The results from these experiments using two different types of cells expressing S protein washed, and added to bulk cultures of spleen cells from MHV-infected mice. As shown in Fig. 2 , splenocytes stimas stimulators are the same as those obtained by Bergmann et al. using MHV-JHM-infected syngeneic spleen ulated in vitro with both peptides for 5 days were able to efficiently lyse targets coated with either peptide in cells. They showed that when S protein was processed endogenously, the H-2K b -restricted epitope was not recsecondary cytotoxicity assays. These results suggested that both epitopes were recognized by spleen-derived lymphocytes in secondary CTL assays. Three independent studies showed that spleen-derived CD8
/ cytotoxic T cells from intraperitoneally inTo compare the CTL precursor frequency for the two epitopes, limiting dilution analyses (LDA) using spleenfected B6 mice recognize the H-2D b -but not the H-2K brestricted epitope in secondary CTL assays. First, Bergderived lymphocytes from B6 mice intraperitoneally infected with MHV-JHM 8 days previously and from naive B6 mice were performed (Fig. 3) . Both virus-specific memory and effector cells should be present in the spleen at this time (29), although only memory cells may be measured in this secondary CTL assay (30). In these assays, threefold serial dilutions of responder spleen cells from individual mice were plated in a volume of 200 ml in the wells of 96-well round bottom tissue culture plates (Costar, Cambridge, MA) in complete RPMI media supplemented with 5% rat concanavalin A supernatant containing 50 mM methyl-a-D-mannopyranoside. In addition to immune or naive responder splenocytes, individual wells received 5 1 10 5 irradiated (3000 rad) syngeneic spleen cells which had been coated with peptide (10 was greater than 3 standard deviations above the mean suggested that in vivo priming in the spleen was similarly efficient for both epitopes. These data are most consistent with inefficient in vitro stimulation of the H- puter. Forward angle light scatter and side scatter were used to exclude
Many previous experiments have shown that cytotoxic dead cells from analysis. Data were collected on 5,000-10,000 cells.
T cell assays performed after secondary stimulation in vitro are far more sensitive than are primary CTL assays (34 fected syngeneic spleen cells, a step which our study 24, 76-85 (1973 
H-2D
b -restricted epitope in cytotoxicity assays.
9. Yamaguchi, K., Goto, N., Kyuwa, S., Hayami, M., and Toyoda, Y., J. Neuroimmunol. 32, 1-9 (1991).
In contrast to these data, use of peptide-coated sple- frequencies were measured for the two epitopes and
